A novel treatment for persistent intractable hiccups : Continuous cervical epidural block

A novel treatment for persistent intractable hiccups : Continuous cervical epidural block - A novel treatment for persistent intractable hiccups : Continuous cervical epidural block

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015213

Enrollment

Registered

2014-09-21

Start date

2006-02-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Persistent intractable hiccup

Interventions

continuous cervical epidural block : continuous infusion of 4 mL/h of 0.123% ropivacaine with or without daily 6ml bolus of 0.25% ropivacaine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Persistent hiccup bouts lasting more than 48 hours and 2) Intractable hiccups with which medical treatments failed before

Exclusion criteria

Exclusion criteria: 1) For those suffering inflammation 2) For those having bleeding tendency or undertaking anti-coagulation or anti-platelet therapy 3) For those suffering psychiatric disorder 4) Pregnant or Lactating women 5) For those who have history of cardiac infarction in the last three months, or suffering angina pectoralis 6) For those having history of Idiopathic pulmonary fibrosis or interstitial pneumonia

Design outcomes

Primary

Measure	Time frame
Remission rate of persistent intractable hiccups	—

Secondary

Measure	Time frame
Time needed for remission, Adverse effects, Recurrence rate	—

Countries

Asia(except Japan)

Contacts

Public ContactJung eun Kim

Korea University Guro Hospital Anesthesiology and pain medicine

geri200@gmail.com+82-2-2626-1870

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026